Antimicrobial and Immunomodulatory Activities of Dried Extracts of Echinacea Purpurea
DOI:
https://doi.org/10.1590/s2175-97902022e21026Keywords:
Echinacea purpurea, Antimicrobial activity, Immunomodulatory activity, Cafeic acid derivativesAbstract
The use of Echinacea purpurea (EP), a plant native from North America, is widely diffused throughout the world, presenting many pharmacological applications, mainly for the treatment of infections of respiratory and urinary tracts. Due to the widespread commercialization of EP-based products, an effective evaluation of their pharmacological properties is essential to assure efficacy during clinical use. In this study, in vitro tests were performed to evaluate the antimicrobial activity of dried extracts of EP by the microdilution method. In addition, a phagocytosis model was employed to assess the immunomodulatory potential of the extracts. The increase in reactive oxygen species production, as well as the intracellular proliferation rate of Cryptococcus gatti after phagocytosis by macrophages in the presence of EP dried extracts were also evaluated. The analyzed samples showed no significant antibacterial activity; however, a slight antifungal activity was verified. Positive effects of EP extracts on the modulation of cellular immune response were observed in different experiments, indicating that this mechanism may contribute to the control and treatment of infections.
Downloads
References
Aarland RC, Banuelos-Hernandez AE, Fragoso-Serrano M, Sierra-Palacios EC, Leon-Sanchez FD, Perez-Flores LJ. Studies on phytochemical, antioxidant, anti-inflammatory, hypoglycaemic and antiproliferative activities of Echinacea purpurea and Echinacea angustifolia extracts. Pharm Biol. 2017;55(1):649-656.
Aguirre J, Hansberg W, Navarro R. Fungal responses to reactive oxygen species. Med Mycol. 2006;44(Suppl 1):S101-S107.
Ardjomand-Woelkart K, Bauer R. Review and assessment of medicinal safety data of orally used Echinacea preparations. Planta Med. 2016;82(1-2):17-31.
Barnes J, Anderson LA, Gibbons S, Philipson J D. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2005;57(8):929-954.
Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved Standard, 9th ed. CLSI document M07-A9, 2012.
Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts, Approved Standard, 2nd ed. CLSI document M27-A2, 2008.
Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, Approved Standard, 3rd ed. CLSI document M38-A2, 2008.
Dalby-Brown L, Barsett H, Landbo AKR, Meyes AS, Molgaard P. Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low- density lipoproteins. J Agric Food Chem. 2005;53(24):9413- 9423.
De Vita D, Friggeri L, D’Auria FD, Pandolfi F, Piccoli F, Panella S, et al. Activity of caffeic acid derivatives against Candida albicans biofilm. Bioorg Med Chem Lett. 2014;24(6):1502-1505.
Fonseca FN, Papanicolaou G, Hong Lin H, Lau CBS, Kennelly EJ, Cassileth BR, et al. Echinacea purpurea (L.) Moench modulates human T-cell cytokine response. Int Immunopharmacol. 2014;19(1):94-102.
Gyawali R, Ibrahim SA. Natural products as antimicrobial agents. Food Control. 2014;46:412-429.
Hudson JB. Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases. J Biomed Biotechnol. 2012;2012:769896.
Kong J, Luo J, Li B, Yingdong B, Hong H, Wang K, et al. In vitro activity of chlorogenic acid against Aspergillus fumigatus biofilm and gliotoxin production. Exp Therap Med. 2017;13(6):2637-2644.
Manayi A, Vazirian M, Saeidnia S. Echinacea purpurea: pharmacology, phytochemistry and analysis methods. Farmacog Rev. 2015;9(17):63-72.
Moloney MG. Natural products as a source for novel antibiotics. Trends Pharmacol Sci. 2016;37(8):689-701.
Oliveira BG, Santos LFF, Pianetti GA, César IC. A rapid UPLC method for the simultaneous quantitation of caffeic acid derivatives in dried extracts of Echinacea purpurea. J Chromatogr Sci. 2021;59(5):439-444.
Ribeiro NQ, Costa MC, Magalhães TFF, Carneiro HCS, Oliveira LV, Fontes ACL, et al. Atorvastatin as a promising anticryptococcal agent. Int J Antimicrob Agents. 2017;49(6):695-702.
Roesler J, Steinmuller C, Kiderlen A, Emmendorffer TA, Wagner TH, Matthes ML. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria Monocytogenes and Candida Albicans. Int J Immunopharmacol. 1991;13(1):27-37.
Santos JRA, Holanda RA, Frases S, Bravim M, Araujo GS, Santos PC, et al. Fluconazole alters the polysaccharide capsule of Cryptococcus gattii and leads to distinct behaviors in murine cryptococcosis. Plos One 2014;9(11):e112669.
Sharma SM, Anderson M, Schoop SR, Hudson JB. Bactericidal and anti-inflammatory properties of a standardized Echinacea extract (Echinaforce): Dual actions against respiratory bacteria. Phytomedicine. 2010;17(8- 9):563-568.
Sidoryk K, Jaromin A, Filipczak N, Cmoch P, Cybulski M. Synthesis and antioxidant activity of caffeic acid derivatives. Molecules. 2018;23(9):2199.
Stanisavljevi I, Stoji Evi SS, Kovi DV, Veljkovi V, Lazi M. Antioxidant and antimicrobial activities of Echinacea (Echinacea purpurea L.) extracts obtained by classical and ultrasound extraction. Chin J Chem Eng. 2009;17(3):478-48.
Tsai Y, Chiou SY, Chan KC, Sung JM, Lin SD. Caffeic acid derivatives, total phenols, antioxidant and antimutagenic activities of Echinacea purpurea flower extracts. Food Sci Technol. 2012;46(1):169-176.
Zhai Z, Solco A, Lankun W, Wurtele ES, Kohut ML, Murphy PA, et al. Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells indicative of alternative macrophage activation. J Ethnopharmacol. 2009;122(1):76-85.
Zheng Y, Liu J, Cao ML, Deng JM, Kou J. Extrication process of chlorogenic acid in Crofton weed and antibacterial mechanism of chlorogenic acid on Escherichia coli. J Environ Biol. 2016;37(5 Spec No):1049-1055.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
